Company intelligence / Profile preview

Asterand

Detroit, Michigan, United States

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Asterand was a leading Contract Research Organization (CRO) and biotech company specializing in providing human tissue and tissue-based research solutions for drug discovery and development. The company operated a global human tissue biorepository, XpressBANK, and offered drug discovery services through platforms like PhaseZERO, BioMAP, and ProCURE. Focused on target and biomarker validation across various therapeutic areas including inflammatory, autoimmune, respiratory, and cardiovascular diseases, Asterand was acquired by BioIVT in 2017.

Therapeutic areas: ImmunologyCardiovascularEndocrinologyNeurologyPulmonologyOncology
Modalities: Cell therapyRecombinant protein
Industry: Drug Discovery Services

Partnerships

Wayne State University

Beyond the preview

Go deeper on Asterand.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asterand.

Explore the full profile